Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals
| Errataetall: |
CommentOn: J Infect. 2021 Aug;83(2):237-279. - PMID 33989631 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
|---|---|
| Enthalten in: |
The Journal of infection - 83(2021), 4 vom: 12. Okt., Seite e9-e10 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Allen, Niamh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 29.09.2021 Date Revised 03.04.2024 published: Print-Electronic CommentOn: J Infect. 2021 Aug;83(2):237-279. - PMID 33989631 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2021.08.012 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329286331 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329286331 | ||
| 003 | DE-627 | ||
| 005 | 20240403232759.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2021.08.012 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1362.xml |
| 035 | |a (DE-627)NLM329286331 | ||
| 035 | |a (NLM)34384812 | ||
| 035 | |a (PII)S0163-4453(21)00394-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Allen, Niamh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.09.2021 | ||
| 500 | |a Date Revised 03.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: J Infect. 2021 Aug;83(2):237-279. - PMID 33989631 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Spike Glycoprotein, Coronavirus |2 NLM | |
| 700 | 1 | |a Brady, Melissa |e verfasserin |4 aut | |
| 700 | 1 | |a Carrion Martin, Antonio Isidro |e verfasserin |4 aut | |
| 700 | 1 | |a Domegan, Lisa |e verfasserin |4 aut | |
| 700 | 1 | |a Walsh, Cathal |e verfasserin |4 aut | |
| 700 | 1 | |a Doherty, Lorraine |e verfasserin |4 aut | |
| 700 | 1 | |a Riain, Una Ni |e verfasserin |4 aut | |
| 700 | 1 | |a Bergin, Colm |e verfasserin |4 aut | |
| 700 | 1 | |a Fleming, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Conlon, Niall |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 83(2021), 4 vom: 12. Okt., Seite e9-e10 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:83 |g year:2021 |g number:4 |g day:12 |g month:10 |g pages:e9-e10 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2021.08.012 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 83 |j 2021 |e 4 |b 12 |c 10 |h e9-e10 | ||